Australia's largest stock trading and investment forum Australia's #1 stock forum

Qbiotics, page-150

First 150 Last

Share
Profile

Follow
paperclip

2,444 Posts.

18/11/20

13:24

Post #: 48959124
Share

Originally posted by Rajenp5: ↑

Standard of care treatment which Stelfonta will be substituting for is surgery/ excision, and chemo which is not that effective. And Gordon has implied cost will be matched. Imagine that these will cost more than $500.
Next markets which qbiotics are pursuing will be China and Japan. Needs registration in these countries which will be very dignificant. So revenue building with Stelfonta still very much in its infancy.

Again ridiculous that vets don't have access in Oz. Laughable

Expand

so maybe $500 plus per treatment , half for virbac half for qbiotics , so above numbers stand up'ish. pop a PE of 10 on this annual revenue of $190 million = company value $1900million. 390million shares = $4.90/share ( US figures only )
1 Upvote

Reply

Top Stories

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Microcap Wrap: 5 explorers with news out today

RCE

Recce's R327 found effective against E.coli during clinical trial

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

There are more pages in this discussion • 1,091 more messages in this thread...

First 150 Last

SPONSORED BY